Zhao Song

Song Zhao, M.D., PhD


Specialties
  • Hematology
  • Medical Oncology
Accepting New Patients
1221 Madison
Suite 1020
Seattle, WA 98104
206-386-9501
206-386-9547

General Information


Biography
To provide the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches.
Specialties
  • Hematology
  • Medical Oncology
Education Background
Medical School: Peking Union Medical College, Beijing, China
Residency: North Shore University Hospital, Internal Medicine
Fellowship: University of Washington School of Medicine , Oncology/Hematology
Graduate School: University of Texas Health Science Center at San Antonio, Molecular Medicine
Postdoctoral Research: Memorial Sloan-Kettering Cancer Center, New York
Languages
  • English
  • Chinese - Mandarin
Personal Interests
Dr Zhao enjoys spending time with my family, hiking, camping and playing soccer.

Publications

Publications
Zhang SQ, Zhao S, Min JM, Wang K, Liu SL, Zheng D.X. (1998) Z-ajoene induces tumor cell death by apoptosis. Chin. Sci. Bulletin, 43: 961-965.

Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, Lee E.Y.-H. P. (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18:7883-7899.

Zhao S, Weng YC, Yuan SS, Lin YT, Hsu HC, Lin SC, Gerbino E, Song MH, Zdzienicka MZ, Gatti RA, Shay JW, Ziv Y, Shiloh Y, Lee E.Y.-H. P. (2000) Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature, 405: 473-477.

Yazdi PT, Wang Y, Zhao S, Patel N, Lee E.Y.-H.P., Qin J. (2002) SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes & Development, 16(5): 571-582.

Yuan SS, Su JH, Hou MF, Yang FW, Zhao S, Lee E.Y.-H. P. (2002) Arsenic-induced Mre11 phosphorylation is cell cycle-dependent and defective in NBS cells. DNA Repair, 1(2): 137-142.

Zhao S, Renthal W, Lee E.Y.-H. P. (2002) Functional Analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses. Nucleic Acids Research, 30(22): 4815-4822.

Lee F, Harris WP, Cheng HH, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter MP, Yu EY, Wright J.L. (2013) Pathologic Response Rates of Gemcitabine/Cisplatin Vs. Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer. Advances in Urology, 2013: 317190.

Mossanen M, Lee F, Cheng HH, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter MP, Yu EY, Wright J.L. (2014) Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder. Clin Genitourin Cancer. 12(3): 210-213.

Zhao S and Yu E.Y. (2013) Castrate Resistant Prostate Cancer: Post-Docetaxel Management. Current Opinions in Urology, 23(3): 201-207.

Zhao S and Nelson P.S. (2013) Leveraging the Species Barrier to Advance Cancer Therapy. Nature Genetics, 45(7):718-20.

James AC, Lee F, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY, Wright J.L. (2014) Role of Maximal Endoscopic Resection Before Cystectomy for Invasive Urothelial Bladder Cancer. Clinical Genitourinary Cancer. 12(4): 287-291.

Huber RM, Lucas JM, Gomez-Sarosi LA, Coleman I, Zhao S, Coleman R, Nelson P.S. (2015) DNA damage induces GDNF secretion in the tumor microenvironment with paracrine effects promoting prostate cancer treatment resistance. Oncotarget. 6(4): 2134-2147.

ABSTRACTS

Zhao S, Coleman I, Coleman R, and Nelson P.S. (2013) PARP inhibitors attenuate docetaxel resistance by suppressing a tumor microenvironment-associated secretory program (abstract# e22212). American Society of Clinical Oncology Annual Meeting 2013.

James AC, Lee F, Harris WP, Cheng HH, Zhao S, Gore JL, Lin DW, Porter MP, Yu EY, Wright J.L. Role of maximal endoscopic resection prior to cystectomy for invasive urothelial bladder cancer (2013) American Urologic Association Annual Meeting; San Diego, CA 2013

Mossanen M, Lee F, Cheng H, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore J, Porter M, Yu E, and Wright J. Non-Response to Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Cell Carcinoma of the Bladder (2013) American Urologic Association Annual Meeting; San Diego, CA 2013

Clinical Experience

Specialties
  • Hematology
  • Medical Oncology
Clinical Interests
  • amyloidosis
  • anemia
  • b12 deficiency anemia
  • bladder cancer
  • cancer
  • cancer chemotherapy
  • cancer during pregnancy
  • cancer survivorship
  • egfr mutation
  • endocrine complications of cancer therapy
  • hellp syndrome
  • hemolytic uremic syndrome
  • heparin induced thrombocytopenia
  • hereditary spherocytosis
  • histiocytosis
  • idiopathic thrombocytopenic purpura
  • iron deficiency anemia
  • leukopenia
  • malignant neoplasm of prostate
  • maternal hematologic disorders
  • myelodysplasia
  • myelodysplastic syndrome
  • neutropenia
  • pancytopenia
  • plasma cell dyscrasia
  • polycythemia
  • pulmonary metastases
  • renal cancer
  • rh incompatibility
  • secondary polycythemia
  • teratogen exposure
  • testicular cancer
  • thalassemia
  • thrombocytopenia
  • thrombophilia
  • thrombotic thrombocytopenic purpura
  • unknown primary cancer

Reviews

Patient Ratings and Comments
 

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey. Responses are measured on a 10-point scale, with 10 being the best score. These scores are then translated to a 5-point scale in order to display results in a 5-star rating. Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.7 out of 5 (54 Ratings, 10 Comments)

50

07/26/2016
I went for a second opinion and selected that doctor. Dr. Zhao didn't think I should worry about my illness [...] and didn't think I should learn about my disease. When I called for more information, his assistant had to look it up on the internet.
100

04/19/2016
Dr. Zhao is great.
100

03/31/2016
Thank you, Dr. Zhao.
100

03/30/2016
Dr. Zhao is very professional, concerned about any issues I may have had.
100

03/29/2016
Explained things very thoroughly, left office with all my questions answered.
100

02/17/2016
Good experience which I've come to expect.
90

02/11/2016
After one visit, he helped me, when I had been asking other doctors to double check for years! He really listened to what I had to say.
100

01/19/2016
Very kind and empathetic provider!
100

01/19/2016
Dr. Zhao is an exemplary good provider.
100

01/11/2016
Dr. Zhao is a great person, great listener, great communicator and great doctor with a great team of staff members.
1221 Madison
Suite 1020
Seattle, WA 98104
206-386-9547
Affiliated Facilities